Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$55.43

0.38 (0.69%)

15:06
10/09/16
10/09
15:06
10/09/16
15:06

Bristol-Myers reports CheckMate-275 data on Opdivo in urothelial cancer

Bristol-Myers Squibb announced results from the CheckMate -275 trial, in which Opdivo had a confirmed objective response rate, the primary endpoint, of 19.6% in platinum-refractory patients with metastatic urothelial carcinoma. Responses were observed in both PD-L1 expressors and non-expressors. The confirmed ORR in patients expressing PD-L1 greater than or equal to 1% was 23.8%, and 16.1% in patients expressing PD-L1 less than 1%. In patients expressing PD-L1 greater than or equal to 5%, the confirmed ORR was 28.4%, and 15.8% in patients expressing PD-L1 less than 5%. The median duration of response was not reached in the overall population with a minimum follow-up of six months, and responses were ongoing in 77% of patients. Among the 52 patients who responded to treatment, the median time to a response was 1.9 months. The median PFS was 2.0 months in all treated patients, 1.87 months for patients with PD-L1 less than 1%, and 3.55 months in patients with PD-L1 greater than or equal to 1%. The median OS was 8.74 months in all treated patients, 5.95 months in patients with PD-L1 less than 1%, and 11.3 months in patients with PD-L1 expression greater than or equal to 1%. The safety profile of Opdivo in this study was consistent with the safety profile of Opdivo in other tumor types. Overall, 4.8% of patients discontinued therapy due to treatment-related AEs of any grade, and 3.0% discontinued therapy due to grade 3-4 treatment-related AEs. The data will be presented at the 2016 European Society for Medical Oncology Congress.

  • 09

    Oct

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers
$55.43

0.38 (0.69%)

09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.

TODAY'S FREE FLY STORIES

GE

General Electric

$27.55

-0.23 (-0.83%)

18:05
06/22/17
06/22
18:05
06/22/17
18:05
Hot Stocks
Concept Laser, LAUAK sign LOI for additive manufacturing collaboration »

Concept Laser, a GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 02

    Oct

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

18:05
06/22/17
06/22
18:05
06/22/17
18:05
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

OKE

Oneok

$47.79

0.38 (0.80%)

, OKS

Oneok Partners

$46.94

0.44 (0.95%)

17:59
06/22/17
06/22
17:59
06/22/17
17:59
Hot Stocks
Oneok and Oneok Partners merger recommended by two proxy advisory firms »

Oneok (OKE) and Oneok…

OKE

Oneok

$47.79

0.38 (0.80%)

OKS

Oneok Partners

$46.94

0.44 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$27.55

-0.23 (-0.83%)

17:55
06/22/17
06/22
17:55
06/22/17
17:55
Conference/Events
Economic Club of New York to host a meeting »

The Economic Club of New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 02

    Oct

SGH

Smart Global

$16.20

0.45 (2.86%)

, IDRA

Idera Pharmaceuticals

$1.73

0.02 (1.17%)

17:52
06/22/17
06/22
17:52
06/22/17
17:52
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Smart…

SGH

Smart Global

$16.20

0.45 (2.86%)

IDRA

Idera Pharmaceuticals

$1.73

0.02 (1.17%)

BAC

Bank of America

$22.93

-0.2 (-0.86%)

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

SONC

Sonic

$27.50

-0.02 (-0.07%)

AMSWA

American Software

$11.97

0.9 (8.13%)

OCUL

Ocular Therapeutix

$11.54

0.5 (4.53%)

PIR

Pier 1 Imports

$5.14

0.08 (1.58%)

WSM

Williams-Sonoma

$47.18

0.48 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 28

    Jun

  • 29

    Jun

  • 19

    Jul

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

17:52
06/22/17
06/22
17:52
06/22/17
17:52
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

SUN

Sunoco

$30.11

0.69 (2.35%)

17:51
06/22/17
06/22
17:51
06/22/17
17:51
Hot Stocks
Sunoco CEO Bob Owens to retire, Joe Kim named COO »

Sunoco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

, TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

17:48
06/22/17
06/22
17:48
06/22/17
17:48
Hot Stocks
Novartis: FDA approves Tafinlar-Mekinist combo in non-small cell lung cancer »

Novartis (NVS) announced…

NVS

Novartis

$86.34

3.78 (4.58%)

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

, LH

LabCorp

$150.34

4.13 (2.82%)

17:34
06/22/17
06/22
17:34
06/22/17
17:34
Hot Stocks
Thermo Fisher says FDA grants premarket approval for Oncomine Dx Target Test »

Thermo Fisher (TMO)…

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

LH

LabCorp

$150.34

4.13 (2.82%)

NEO

NeoGenomics

$8.70

0.21 (2.47%)

CGIX

Cancer Genetics

NVS

Novartis

$86.34

3.78 (4.58%)

PFE

Pfizer

$34.06

0.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 11

    Jul

  • 12

    Jul

  • 02

    Aug

  • 27

    Aug

NGHC

National General

17:32
06/22/17
06/22
17:32
06/22/17
17:32
Syndicate
Breaking Syndicate news story on National General »

National General files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

NG

NovaGold

$4.42

0.13 (3.03%)

, ABX

Barrick Gold

$16.09

0.35 (2.22%)

17:29
06/22/17
06/22
17:29
06/22/17
17:29
Hot Stocks
NovaGold and Barrick Gold to advance Donlin Gold project with $8M drill program »

NovaGold (NG) and partner…

NG

NovaGold

$4.42

0.13 (3.03%)

ABX

Barrick Gold

$16.09

0.35 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

PRXL

Parexel

$87.11

-0.14 (-0.16%)

17:29
06/22/17
06/22
17:29
06/22/17
17:29
Hot Stocks
Breaking Hot Stocks news story on Parexel »

Starboard liquidates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

17:28
06/22/17
06/22
17:28
06/22/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

LMT

Lockheed Martin

$280.43

-2.56 (-0.90%)

17:27
06/22/17
06/22
17:27
06/22/17
17:27
Hot Stocks
Lockheed Martin awarded $130.8M government contract »

Lockheed Martin Rotary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$201.26

-2.63 (-1.29%)

17:26
06/22/17
06/22
17:26
06/22/17
17:26
Hot Stocks
General Dynamics' Electric Boat awarded $203M government contract »

Electric Boat Corp.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$48.97

0.54 (1.12%)

17:23
06/22/17
06/22
17:23
06/22/17
17:23
Periodicals
Breaking Periodicals news story on American Airlines »

American Airlines CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 07

    Jul

QSR

Restaurant Brands

$61.93

0.08 (0.13%)

17:21
06/22/17
06/22
17:21
06/22/17
17:21
Periodicals
Restaurant Brands to cut use of antibiotics in chicken supply, Reuters reports »

Restaurant Brands, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

EMR

Emerson

$58.73

0.09 (0.15%)

17:17
06/22/17
06/22
17:17
06/22/17
17:17
Periodicals
Emerson in talks to buy software firm Paradigm, Bloomberg says »

Emerson said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.52

1.47 (4.73%)

17:15
06/22/17
06/22
17:15
06/22/17
17:15
Conference/Events
Teva management to meet with Maxim »

Institutional dinner to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 30

    Aug

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

17:10
06/22/17
06/22
17:10
06/22/17
17:10
Hot Stocks
Bed Bath & Beyond says gross margin approximately 36.5% in Q1 »

Says Q1 EPS ot 53c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

LC

LendingClub

$5.70

0.17 (3.07%)

17:05
06/22/17
06/22
17:05
06/22/17
17:05
Hot Stocks
LendingClub sees using club structure for future transactions »

LendingClub closed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$204.35

0.9 (0.44%)

17:03
06/22/17
06/22
17:03
06/22/17
17:03
Hot Stocks
Teleflex says subsidiary issues recall of Venture catheters »

Teleflex announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ALLY

Ally Financial

$20.39

0.34 (1.70%)

, AXP

American Express

$82.25

0.04 (0.05%)

17:01
06/22/17
06/22
17:01
06/22/17
17:01
Hot Stocks
All 34 banks exceed minimum requirements of Fed Stress Test »

Shares of big banks were…

ALLY

Ally Financial

$20.39

0.34 (1.70%)

AXP

American Express

$82.25

0.04 (0.05%)

BNPQY

BNP Paribas

$34.42

-0.18 (-0.52%)

BAC

Bank of America

$22.93

-0.2 (-0.86%)

BNK

C1 Financial

BBT

BB&T

$43.34

-0.31 (-0.71%)

BBVA

Banco Bilbao

$8.13

-0.02 (-0.25%)

BMO

Bank of Montreal

$70.67

1.21 (1.74%)

COF

Capital One

$80.39

-0.49 (-0.61%)

CIT

CIT Group

$47.85

0.04 (0.08%)

C

Citi

$63.62

-0.21 (-0.33%)

CFG

Citizens Financial

$34.98

-0.22 (-0.63%)

CMA

Comerica

$71.42

-0.9 (-1.24%)

DB

Deutsche Bank

$16.74

-0.16 (-0.95%)

DFS

Discover

$60.24

-0.12 (-0.20%)

FITB

Fifth Third

$25.14

-0.25 (-0.98%)

GS

Goldman Sachs

$219.77

-2.72 (-1.22%)

HSBC

HSBC

$43.31

-0.16 (-0.37%)

HBAN

Huntington Bancshares

$12.94

-0.12 (-0.92%)

JPM

JPMorgan

$87.02

-0.1 (-0.11%)

KEY

KeyCorp

$18.20

-0.19 (-1.03%)

MTB

M&T Bank

$159.49

-1.54 (-0.96%)

MS

Morgan Stanley

$44.61

-0.3 (-0.67%)

MTU

Mitsubishi UFJ

$6.48

0.06 (0.93%)

NTRS

Northern Trust

$94.34

-0.05 (-0.05%)

PNC

PNC Financial

$120.76

-1.57 (-1.28%)

RF

Regions Financial

$13.84

-0.12 (-0.86%)

SAN

Banco Santander

$6.51

-0.03 (-0.46%)

STT

State Street

$88.68

-0.7 (-0.78%)

STI

SunTrust

$54.73

-0.56 (-1.01%)

TD

Toronto-Dominion

$49.32

0.51 (1.04%)

USB

U.S. Bancorp

$51.30

-0.7 (-1.35%)

WFC

Wells Fargo

$52.49

-0.49 (-0.92%)

ZION

Zions Bancorp

$42.30

-0.03 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 14

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 20

    Jul

  • 21

    Jul

  • 21

    Jul

  • 21

    Jul

  • 25

    Jul

  • 27

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

HAE

Haemonetics

$39.18

-0.91 (-2.27%)

17:01
06/22/17
06/22
17:01
06/22/17
17:01
Hot Stocks
Haemonetics forms Scientific Advisory Council »

Haemonetics announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ASCMA

Ascent Capital

$15.00

0.25 (1.69%)

16:55
06/22/17
06/22
16:55
06/22/17
16:55
Hot Stocks
Breaking Hot Stocks news story on Ascent Capital »

Gabelli cuts stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.